In vitro evaluation of topical biocide and antimicrobial susceptibility of Staphylococcus pseudintermedius from dogs

被引:28
|
作者
Valentine, Becky K. [1 ]
Dew, Walter [2 ]
Yu, Anthony [1 ]
Weese, J. Scott [2 ]
机构
[1] Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON N1G 2W1, Canada
[2] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada
关键词
TEA-TREE OIL; FUSIDIC ACID; METICILLIN-RESISTANT; AUREUS; CHLORHEXIDINE; EFFICACY; ANTIBIOTICS; INTERMEDIUS; MUTATIONS; MUPIROCIN;
D O I
10.1111/j.1365-3164.2012.01095.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Staphylococcus pseudintermedius is an important canine pathogen, and the emergence and widespread dissemination of meticillin-resistant strains (MRSP) is of significant concern. Multidrug-resistant infections may require alternative approaches, such as the use of topical therapy. There is minimal information about the in vitro susceptibility of meticillin-susceptible S.pseudintermedius (MSSP) and MRSP to biocides and topical antimicrobials. Hypothesis/Objectives The hypothesis was that clinical isolates of MSSP and MRSP would not have universal susceptibility to topical biocides and antimicrobials. The goal of this study was to assess the susceptibility of a collection of S.pseudintermedius isolates to selected antimicrobials and biocides. Animals The study was performed on clinical isolates of MSSP and MRSP from dogs with skin and soft tissue infections collected throughout North America between 2006 and 2008. Methods The minimal inhibitory concentrations (MICs) of chlorhexidine digluconate, benzalkonium chloride, triclosan, accelerated hydrogen peroxide, geranium oil, tea tree oil and grapefruit seed extract were tested for 25 MRSP and 25 MSSP isolates from dogs using the agar dilution method. The MICs of fusidic acid, bacitracin and mupirocin were determined using Etests. Results Triclosan demonstrated excellent activity against all bacterial isolates, with no growth at the lowest concentration evaluated (MIC <= 0.5 mu g/mL). Conversely, grapefruit seed extract did not inhibit growth at the highest concentration tested (MIC > 3.84 mu g/mL). All isolates were susceptible to mupirocin, fusidic acid and bacitracin. There were no significant differences noted in the range, MIC50 or MIC90 between MSSP and MRSP isolates. Conclusions and clinical importance While isolates were susceptible to most of the tested compounds, universal susceptibility to all compounds with potential antimicrobial activity cannot be assumed, and specific testing is required.
引用
收藏
页码:493 / e95
页数:6
相关论文
共 50 条
  • [31] Evaluation of canine-specific minocycline and doxycycline susceptibility breakpoints for meticillin-resistant Staphylococcus pseudintermedius isolates from dogs
    Hnot, Melanie L.
    Cole, Lynette K.
    Lorch, Gwendolen
    Papich, Mark G.
    Rajala-Schultz, Paivi J.
    Daniels, Joshua B.
    [J]. VETERINARY DERMATOLOGY, 2015, 26 (05) : 334 - +
  • [32] Evaluation of minocycline susceptibility of methicillin-resistant Staphylococcus pseudintermedius
    Weese, J. S.
    Sweetman, K.
    Edson, H.
    Rousseau, J.
    [J]. VETERINARY MICROBIOLOGY, 2013, 162 (2-4) : 968 - 971
  • [33] Antimicrobial susceptibility of Staphylococcus intermedius isolated from healthy and diseased dogs
    Shimizu, A
    Wakita, Y
    Nagase, S
    Okabe, M
    Koji, T
    Hayashi, T
    Nagase, N
    Sasaki, A
    Kawano, J
    Yamashita, K
    Takagi, M
    [J]. JOURNAL OF VETERINARY MEDICAL SCIENCE, 2001, 63 (03): : 357 - 360
  • [34] Comparison of the In vitro Activity of Five Antimicrobial Drugs against Staphylococcus pseudintermedius and Staphylococcus aureus Biofilms
    Ferran, Aude A.
    Liu, JingJing
    Toutain, Pierre-Louis
    Bousquet-Melou, Alain
    [J]. FRONTIERS IN MICROBIOLOGY, 2016, 7
  • [35] Antimicrobial susceptibility of methicillin-resistant Staphylococcus pseudintermedius isolated from veterinary clinical cases in the UK
    Maluping, R. P.
    Paul, N. C.
    Moodley, A.
    [J]. BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2014, 71 (02) : 55 - 57
  • [36] In vitro pharmacokinetics/pharmacodynamics evaluation of marbofloxacin against Staphylococcus pseudintermedius
    Quah, Yixian
    Boby, Naila
    Park, Seling-Chlin
    [J]. VETERINARNI MEDICINA, 2020, 65 (03) : 116 - 122
  • [37] Heterogeneity of Staphylococcus pseudintermedius isolates from atopic and healthy dogs
    Fazakerley, Jennifer
    Williams, Nicola
    Carter, Stuart
    McEwan, Neil
    Nuttall, Tim
    [J]. VETERINARY DERMATOLOGY, 2010, 21 (06) : 578 - 585
  • [38] Incidence of Inducible Clindamycin Resistance in Staphylococcus pseudintermedius from Dogs
    Gold, Randi M.
    Lawhon, Sara D.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (12) : 4196 - 4199
  • [39] Characterization of the biofilm forming ability of Staphylococcus pseudintermedius from dogs
    Singh, Ameet
    Walker, Meagan
    Rousseau, Joyce
    Weese, Jeffrey Scott
    [J]. BMC VETERINARY RESEARCH, 2013, 9
  • [40] Characterization of Staphylococcus pseudintermedius isolated from diseased dogs in Lithuania
    Ruzauskas, M.
    Couto, N.
    Pavilonis, A.
    Klimiene, I.
    Siugzdiniene, R.
    Virgailis, M.
    Vaskeviciute, L.
    Anskiene, L.
    Pomba, C.
    [J]. POLISH JOURNAL OF VETERINARY SCIENCES, 2016, 19 (01): : 7 - 14